This abnormal ECG would be typical following an overdose on which of the following medications?
- Amitriptyline
- Buspirone
- Citalopram
- Haloperidol
Answer: 1
Amitriptyline
TCA Poisoning & ECGs
The above shows classic ECG findings seen with tricyclic antidepressant (TCA) poisoning. Cardiac toxicity from TCA is secondary to cardiac sodium (Na+) channel blockade, cardiac potassium (K+) efflux blockade, and direct alpha-1 antagonism [1,2]. Cardiac Na+ channel blockade leads to a widening of the QRS interval, cardiac K+ efflux blockade causes widening of the QTc interval, and alpha-1 antagonism causes hypotension [2]. TCA toxicity produces characteristic ECG findings including QRS interval widening >100 msec and terminal R wave in aVR (defined as ≥3 mm in aVR) [3]. QRS widening ≥160 msec increases the risk for ventricular dysrhythmias and >100 msec increases the risk of seizures [3,4].
Presentation
TCAs such as amitriptyline are used for depression, neuralgic pain, migraines, enuresis, and ADHD. Their therapeutic mechanism is inhibition of norepinephrine and/or serotonin reuptake; however, they also have anticholinergic, antihistamine, and anti-alpha-1 adrenergic effects [1].
Following overdose, patients will initially have an anticholinergic toxidrome. This may include altered mental status, dry mucosal membranes, urinary retention, mydriasis, tachycardia, and anhidrosis [2]. Seizures often occur in TCA overdose and are likely related to the increased amounts of norepinephrine, anticholinergic tone, Na+ channel blockade, and GABA inhibition [1,5]. Cardiac conduction disturbances may degenerate into malignant ventricular dysrhythmias and cardiac arrest [1-5].
Treatment
The first line agent for the treatment of cardiac Na+ channel blockade is sodium bicarbonate. Sodium will increase the electrochemical gradient of the Na+ channels assisting in the generation of action potentials in the Purkinje fibers [6]. The bicarbonate will alkalize the serum decreasing the free and ionized fraction of the TCA that is available to bind to the Na+ channel [6]. Initial bolus dose is 1-2 mEq/kg, repeated every 5 minutes until narrowing of the QRS interval has occurred or limited by hypernatremia or alkalosis [1,2]. These numerical value limitations are frequently set at 155 mmol/L for serum sodium and 7.55 for serum pH [2,7].
Seizure management with benzodiazepines and barbiturates is recommended, as seizures cause acidosis which can worsen cardiotoxicity [1,2]. Extracorporeal membrane oxygenation (ECMO) has also been used in severe cases [1,2].
Take Home Bedside Pearls
- TCA toxicity causes cardiac Na+ channel blockade, leading to an abnormal ECG with widened QRS interval and arrhythmia.
- Sodium bicarbonate is the preferred treatment for TCA induced QRS prolongation.
- Aggressive seizure management with benzodiazepines is important as acidosis can precipitate worsening cardiotoxicity.
This post was expert peer-reviewed by Dr. Michele Burns, Dr. Bryan Judge, & Dr. Louise Kao.
References
- Liebelt E. Cyclic Antidepressants. In: Goldfrank’s Toxicologic Emergencies. 10e Eds. Robert S. Hoffman et al. New York, NY. McGraw-Hill. 2015.
- Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J 2001;18(4): 236-241.
- Liebelt E et al. ECG lead AVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. Aug 1995; 26(2):195–201.
- Boehnert M. Value of the QRS Duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. NEJM. Aug 22 1985; 13(8):474-479.
- Citak A et al. Seizures associated with poisoning in children: Tricyclic antidepressant intoxication. Pediatr Int. 2006; 48(6): 582–85.
- Bruccoleri RE & Burns M. A Literature review of the use of sodium bicarbonate for the treatment of QRS widening. J Med Toxicol 2016; 12(1):121–29.
- Seger DL, Hantsch C, Zavoral T, Wrenn K. Variability of recommendations for serum alkalinization in tricyclic antidepressant overdose: a survey of U.S. Poison Center medical directors. J Toxicol Clin Toxicol 2003; 41(4):331–338.